STERIS Q3 EPS $2.32 (+11% YoY); revenue $1.4B (+6%); guidance trimmed on currency

STERIS plc

2025-Q3 EPS reported $4.73 vs consensus $2.37 ▲ beat (+99.2%)

Adjusted EPS of $2.32 vs $2.09 YoY; GAAP EPS $1.75 vs $1.49; revenue $1.4B (+6% as reported, +6% organic constant currency)
Healthcare revenue $976M (+7%); consumables +9%, service +13%, capital equipment -5%
AST revenue $258.1M (+10%); Life Sciences -7% to $136.4M on CECS divestiture and lower capital equipment
Fiscal 2025 outlook: revenue growth ~6% (prior 6.5-7.5%), adjusted EPS $9.05-$9.15 (from $9.05-$9.25), currency headwind ~$0.10
Nine-month free cash flow $588.1M vs $457.0M YoY; capex expected ~$360M

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.